Ocular complications in the treatment of joint disease.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D000493:Allopurinol / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002648:Child; D002738:Chloroquine / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006046:Gold / Q000009:adverse effects; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D007592:Joint Diseases / Q000188:drug therapy; D008297:Male; D010653:Phenylbutazone / Q000009:adverse effects; D012459:Salicylates / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D012459:Salicylates; D000493:Allopurinol; D006046:Gold; D002738:Chloroquine; D010653:Phenylbutazone; D007213:Indomethacin